Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.
about
Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.Targeting RAS - will GPR31 deliver us a new path forward?Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines.Neuropeptide G Protein-Coupled Receptors as Oncotargets.
P2860
Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Pharmacotherapeutic Targeting ...... erapies and Emerging Concepts.
@en
Pharmacotherapeutic Targeting ...... erapies and Emerging Concepts.
@nl
type
label
Pharmacotherapeutic Targeting ...... erapies and Emerging Concepts.
@en
Pharmacotherapeutic Targeting ...... erapies and Emerging Concepts.
@nl
prefLabel
Pharmacotherapeutic Targeting ...... erapies and Emerging Concepts.
@en
Pharmacotherapeutic Targeting ...... erapies and Emerging Concepts.
@nl
P2860
P1433
P1476
Pharmacotherapeutic Targeting ...... herapies and Emerging Concepts
@en
P2093
Rosamaria Lappano
P2860
P2888
P304
P356
10.1007/S40265-017-0738-9
P577
2017-06-01T00:00:00Z